Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by chronic abdominal pain, bloating, and changes in bowel movement consistency, which can severely affect quality of life. Subtypes like IBS-C (constipation-predominant IBS) involve specific symptoms such as constipation and can be managed through dietary changes, supplements, and medications.
Health Outcomes
- Absence of Treatment-Related Side Effects
- Acceptability of Cheese Products
- Accurate Enumeration of Viable Probiotic Bacteria
- Achieved Clean Fecal Loading
- Adjusted Intestinal Microbiota Abundance
- Alleviated Constipation
- Alleviated Constipation Symptoms
- Altered Bifidobacterium Profile
- Altered Colonic Microbial Communities
- Altered Dominant Intestinal Bacterial Composition
- Altered Faecal Microbiota Profile
- Altered Fecal Butyrate Levels
- Altered Fecal Metabolite Levels
- Altered Gastrointestinal Health Post-Infection
- Altered Gastrointestinal Microbial Communities
- Altered Gastrointestinal Microbiome Composition
- Altered Gut Metabolome
- Altered Gut Microbial Community
- Altered Gut Microbial Transcriptomic Response
- Altered Intestinal Transit
- Altered Lactobacilli Composition
- Altered Relative Abundance of Specific Bacteria
- Altered Short-Chain Fatty Acid Production
- Altered Short-Chain Fatty Acid Production by Gut Microbiota
- Altered Stool Microbiota Profile
- Attenuated Stress-Induced Changes in Gut Microbiota
- Balanced Gut Microbiome
- Balanced Gut Microbiota
- Balanced Intestinal Microflora
- Changed Stool Consistency
- Changes in Health Status from Probiotic Intervention
- Complete Irritable Bowel Syndrome Symptom Relief
- Complete Resolution of Abdominal Pain
- Confirmed Safety of Oral Probiotic Administration
- Corrected Rapid Colon Transit Pattern
- Counterbalanced Gut Dysbiosis
- Decreased Spontaneous Bowel Movement Frequency in IBS-D
- Degraded Non-Digestible Carbohydrates
- Disrupted Gut Microbiota Distribution
- Effectiveness Compared to Commercial Probiotic
- Elevated Bifidobacterium Levels
- Elevated Fecal Serotonin Levels
- Elevated Short Chain Fatty Acids (SCFAs) Levels
- Enhanced Abundance of Beneficial Bacterial Species
- Enhanced Beneficial Bacteria in Intestinal Microbiota
- Enhanced Beneficial Gut Microbiota
- Enhanced Bifidobacterial Diversity
- Enhanced Bifidobacterial Growth
- Enhanced Digestive Health with Lactose-Hydrolysed LFM
- Enhanced Digestive Process Survival
- Enhanced Diversity of Protective Bifidobacterial Populations
- Enhanced Functional Gut Microbial Pathways
- Enhanced Gastrointestinal Stress Resistance
- Enhanced Goblet Cell Regeneration
- Enhanced Gut Colonization
- Enhanced Gut Flora Composition
- Enhanced Gut Health
- Enhanced Gut Microbiome Health
- Enhanced Gut Microbiota
- Enhanced Gut Microbiota Diversity
- Enhanced Gut Microbiota Maturation
- Enhanced Gut Microbiota Stability
- Enhanced Gut Probiotic Bacteria Propagation
- Enhanced Gut Probiotic Levels
- Enhanced Intestinal Barrier Function
- Enhanced Intestinal Lactobacillus Community
- Enhanced Intestinal Microbiota Maturation
- Enhanced Microbiota Recovery
- Enhanced Parasympathetic Nervous System Activity
- Enhanced Placebo Response
- Enhanced Prebiotic Activity
- Enhanced Probiotic Activity
- Enhanced Probiotic Bacteria Count
- Enhanced Probiotic Growth
- Enhanced Probiotic Gut Adhesion
- Enhanced Probiotic Presence
- Enhanced SCFA Production
- Enhanced Small Intestine Metabolic Function
- Enhanced Tight Junction Integrity
- Exercise-Induced Gastrointestinal Symptoms
- Germination of Probiotics in Small Intestine
- Global Relief of IBS Symptoms
- Gut Colonization by Saccharomyces boulardii
- Healthy Gut Microbiome
- Impaired Intestinal Barrier Function
- Improved 2'-Fucosyllactose Degradation
- Improved Abdominal Pain
- Improved Abdominal Pain Frequency
- Improved Abdominal Pain Severity
- Improved Adhesion of Bifidobacteria
- Improved Apparent Digestibility of Fiber
- Improved Beneficial Intestinal Bacteria
- Improved Beneficial Intestinal Microbiota
- Improved Bifidobacteria Levels
- Improved Bifidobacterium-Dominated Microbiota
- Improved Bifidogenic Response
- Improved Bloating
- Improved Bloating Symptoms
- Improved Bowel Function
- Improved Bowel Function Index
- Improved Bowel Habit Satisfaction
- Improved Bowel Habits
- Improved Bowel Movement Frequency
- Improved Bowel Movements
- Improved Bristol Stool Score
- Improved Bristol Stool Type
- Improved Chronic Constipation
- Improved Colon Pain
- Improved Colonic Delivery
- Improved Colonic Health
- Improved Colonic Microbial Diversity
- Improved Colonic Microenvironment
- Improved Colonic Transit Time
- Improved Colonization of Gastrointestinal Tract by Lactobacilli
- Improved Composite IBS Symptoms
- Improved Constipation
- Improved Constipation Management
- Improved Constipation Relief
- Improved Constipation Symptoms
- Improved Defecation Condition
- Improved Degradability of Acid Detergent Fiber
- Improved Digestibility
- Improved Digestibility of Neutral Detergent Fiber
- Improved Digestive Comfort
- Improved Digestive Function
- Improved Digestive Health
- Improved Digestive Performance
- Improved Digestive Symptoms
- Improved Digestive Viability
- Improved Enjoyment of Life
- Improved Epithelial Permeability
- Improved Faecal Dry Matter
- Improved Fecal Acetate Recovery
- Improved Fecal Lactobacillus Count
- Improved Fecal Microbial Profile
- Improved Fecal Microbiota
- Improved Fecal Microbiota Diversity
- Improved Fecal Score
- Improved Fecal Short-Chain Fatty Acid Levels
- Improved Fecal Water Content
- Improved Fermentation Quality
- Improved Functional Constipation
- Improved Functional Diarrhea Symptoms
- Improved Gastric Emptying Time
- Improved Gastrointestinal Discomfort
- Improved Gastrointestinal Health
- Improved Gastrointestinal Microbiome Balance
- Improved Gastrointestinal Peristalsis
- Improved Gastrointestinal Resilience
- Improved Gastrointestinal Resistance
- Improved Gastrointestinal Score
- Improved Gastrointestinal Symptom Management
- Improved Gastrointestinal Symptom Rating Scale Score
- Improved Gastrointestinal Symptom Relief
- Improved Gastrointestinal Symptom Score
- Improved Gastrointestinal Symptoms
- Improved Gastrointestinal Tolerance
- Improved Gastrointestinal Transit
- Improved Gastrointestinal Well-Being
- Improved General GI Health Status
- Improved Global Evaluation of Patient Score
- Improved Global Symptom
- Improved Gut Adhesion
- Improved Gut Bacterial Diversity
- Improved Gut Barrier Function
- Improved Gut Barrier Morphology
- Improved Gut Comfort
- Improved Gut Dysbiosis
- Improved Gut Flora Diversity
- Improved Gut Flora Modulation
- Improved Gut Health
- Improved Gut Homeostasis
- Improved Gut Integrity
- Improved Gut Microbial Balance
- Improved Gut Microbial Dysbiosis
- Improved Gut Microbial Persistence
- Improved Gut Microbial Population
- Improved Gut Microbial Richness
- Improved Gut Microbiome
- Improved Gut Microbiome Composition
- Improved Gut Microbiome Diversity
- Improved Gut Microbiome Function
- Improved Gut Microbiome Health
- Improved Gut Microbiome Recovery
- Improved Gut Microbiota
- Improved Gut Microbiota Balance
- Improved Gut Microbiota Composition
- Improved Gut Microbiota Composition in Small Intestine
- Improved Gut Microbiota Distribution
- Improved Gut Microbiota Diversity
- Improved Gut Microbiota Fermentation
- Improved Gut Microbiota Growth Medium Suitability
- Improved Gut Microbiota Homeostasis
- Improved Gut Microbiota Richness
- Improved Gut Microbiota Structure
- Improved Gut Microbiota-Related Pathways
- Improved Gut Microflora
- Improved Gut Motility
- Improved Gut Permeability
- Improved Gut Protection
- Improved Gut Resilience
- Improved Gut Stress Resistance
- Improved Gut Tolerance
- Improved Gut-Brain Axis Function
- Improved Gut-Brain Axis Homeostasis
- Improved Health-related Quality of Life
- Improved Host-Gut Microbiota Related Molecular Adaptation
- Improved Host-Probiotic Interaction
- Improved IBS Composite Symptom Score
- Improved IBS Severity
- Improved IBS Symptom Score
- Improved Incomplete Defecation
- Improved Intestinal Barrier
- Improved Intestinal Barrier Function
- Improved Intestinal Cell Adhesion
- Improved Intestinal Cell Integrity
- Improved Intestinal Cell Viability
- Improved Intestinal Defense
- Improved Intestinal Environment
- Improved Intestinal Epithelial Cell Function
- Improved Intestinal Epithelium Recovery
- Improved Intestinal Flora
- Improved Intestinal Flora Balance
- Improved Intestinal Flora Diversity
- Improved Intestinal Function
- Improved Intestinal Health
- Improved Intestinal Health from Zinc Deficiency Prevention
- Improved Intestinal Immune Responsiveness
- Improved Intestinal Immunity
- Improved Intestinal Immunomodulatory Function
- Improved Intestinal Integrity
- Improved Intestinal LAB Viability
- Improved Intestinal Metabolism
- Improved Intestinal Microbial Composition
- Improved Intestinal Microbiota Balance
- Improved Intestinal Microenvironment
- Improved Intestinal Microflora Balance
- Improved Intestinal Motility
- Improved Intestinal Transit
- Improved Lactobacillus Abundance
- Improved Lactobacillus Counts
- Improved Microbial Community Composition
- Improved Microbial Diversity
- Improved Microbial Metabolism Regulation
- Improved Microbiota Activity
- Improved Microbiota Diversity
- Improved Microbiota Profile
- Improved Microflora Composition
- Improved Mucosal Barrier Function
- Improved Niche Colonization
- Improved Oral Tolerance
- Improved Overall Gastrointestinal Symptoms
- Improved Overall Symptom Relief
- Improved Overall Symptom Score
- Improved Overall Symptoms
- Improved PAC-QoL Score
- Improved Palatability and Textural Quality
- Improved Patient Satisfaction
- Improved Perceived Intestinal Habits
- Improved Postinfective IBS Symptoms
- Improved Prebiotic Index
- Improved Probiotic Function
- Improved Probiotic Functionality
- Improved Probiotic Functionality for Functional Foods Development
- Improved Probiotic Product Stability
- Improved Probiotic Safety
- Improved Probiotic Suitability
- Improved Progressive Motility
- Improved Quality of Life for IBS-D Patients
- Improved Quality of Probiotic Food Products
- Improved Recovery of Intestinal Flora
- Improved Response to Prebiotics
- Improved Secondary Symptoms
- Improved Short-Chain Fatty Acids Levels
- Improved Spontaneous Bowel Movements
- Improved Stability of Gut Microbiota
- Improved Starch Degradation Potential
- Improved Stool Characteristics
- Improved Stool Consistency
- Improved Stool Formation
- Improved Stool Frequency
- Improved Stool Softness
- Improved Stool Symptoms
- Improved Stool Volume
- Improved Survival of Probiotic Bacteria
- Improved Symptom Control
- Improved Symptom Relief for Lactose Intolerance
- Improved Symptom Relief in IBS-D Patients
- Improved Symptom Score
- Improved Symptoms
- Improved Symptoms of Functional Bowel Disorders
- Improved Tight Junction Protein Localization
- Improved Tolerability of Bifidobacterium breve BBG-01
- Improved Tolerability of Bifidobacterium lactis HN019
- Improved Tolerability of HN019 Supplementation
- Improved Tolerance to High Doses of Probiotics
- Improved Tolerance to Intestinal Conditions
- Improved Tolerance to Lactobacillus rhamnosus PRSF-L477
- Improved Viability of Lactic Acid Bacteria
- Improved Whole Gut Transit Time
- Increase in Beneficial Bifidobacterial Species
- Increased Abdominal Symptoms in Children Taking Antibiotics
- Increased Abundance of Beneficial Gut Genera
- Increased Abundance of Beneficial Microbes
- Increased Abundance of Beneficial SCFAs-Producing Bacteria
- Increased Abundance of Bifidobacterium
- Increased Abundance of Bifidobacterium animalis
- Increased Abundance of Gut Bacteria
- Increased Abundance of Peptostreptococcaceae
- Increased Abundance of Specific Bacterial Species
- Increased Bacteroides Levels in the Intestine
- Increased Bacteroides ovatus Abundance
- Increased Beneficial Bacteria Levels
- Increased Beneficial Bacteria Populations
- Increased Beneficial Bifidobacteria
- Increased Beneficial Gut Lactic Acid Bacteria
- Increased Beneficial Gut Microbiota
- Increased Beneficial Gut Microbiota Abundance
- Increased Beneficial Intestinal Microorganisms
- Increased Bifidobacteria Growth
- Increased Bifidobacteria Levels
- Increased Bifidobacteria Levels in Intestine
- Increased Bifidobacteria in Colon
- Increased Bifidobacteria in Fecal Microbiota
- Increased Bifidobacteria in Intestinal Microbiota
- Increased Bifidobacteriaceae Abundance
- Increased Bifidobacterial Counts
- Increased Bifidobacterial Development
- Increased Bifidobacterial Population
- Increased Bifidobacterial Populations in Feces
- Increased Bifidobacterium Animalis in Stool
- Increased Bifidobacterium Breve Count in Stool
- Increased Bifidobacterium Concentration
- Increased Bifidobacterium Diversity
- Increased Bifidobacterium Levels
- Increased Bifidobacterium Levels in Feces
- Increased Bifidobacterium Persistence Duration
- Increased Bifidobacterium Species
- Increased Bifidobacterium lactis GCL2505 Intestinal Proliferation
- Increased Bifidobacterium lactis Proliferation in the Intestine
- Increased Bifidobacterium longum Relative Abundance
- Increased Bifidobacterium-Dominated Gut Microbiota
- Increased Bloating
- Increased Bowel Movement Frequency
- Increased Bowel Movement Regularity
- Increased Butyrate Levels
- Increased Butyrate Production
- Increased Butyrate Production in Healthy Subjects
- Increased Butyrate-Producing Gut Bacteria
- Increased Cecal Lactobacilli Levels
- Increased Cellulolytic Bacterial Count
- Increased Colon Barrier Biomarkers
- Increased Colon Lactobacilli
- Increased Colonic Butyric Acid Concentrations
- Increased Colonic Fermentation
- Increased Colonic SCFA Levels
- Increased Commensal Lactobacilli Levels
- Increased Complete Spontaneous Bowel Movements
- Increased Cultivable Lactobacilli
- Increased Defecation Frequency
- Increased Diarrhea Incidence
- Increased Digestive Problem
- Increased Endogenous Bifidobacteria Levels
- Increased Faecal Bifidobacterium Lactis Content
- Increased Faecal Serotonin Levels
- Increased Faecalibacterium prausnitzii Levels
- Increased Faecalibacterium prausnitzii Population
- Increased Fecal Acetate Levels
- Increased Fecal Acetic Acid Concentration
- Increased Fecal Bifidobacteria
- Increased Fecal Bifidobacteria Levels
- Increased Fecal Bifidobacterial Populations
- Increased Fecal Bifidobacterium Count
- Increased Fecal Bifidobacterium breve Levels
- Increased Fecal Bifidobacterium lactis Levels
- Increased Fecal Butyric Acid Concentration
- Increased Fecal Concentration of Propionic Acid
- Increased Fecal Excretion
- Increased Fecal Lactic Acid Bacteria Concentration
- Increased Fecal Lactic Acid Concentration
- Increased Fecal Lactobacilli
- Increased Fecal Lactobacilli Levels
- Increased Fecal Lactobacilli Population
- Increased Fecal Lactobacillus Paracasei Levels
- Increased Fecal Lactobacillus reuteri Concentration
- Increased Fecal Lactobacillus reuteri Levels
- Increased Fecal Moisture
- Increased Fecal Moisture Content
- Increased Fecal Output
- Increased Fecal Pellet Count
- Increased Fecal Probiotic Strains
- Increased Fecal Propionic Acid Levels
- Increased Fecal Water Content
- Increased Fiber Carbohydrate Degradation Rate
- Increased Frequency of Complete Spontaneous Bowel Movements
- Increased Frequency of Loose or Watery Stools
- Increased Fullness
- Increased Functional Gene Abundance in Small Intestine
- Increased Gastrointestinal Discomfort
- Increased Gastrointestinal Symptoms
- Increased Gut Beneficial Microbes
- Increased Gut Bifidobacterium Count
- Increased Gut Lactic Acid Bacteria Count
- Increased Gut Lactobacillus plantarum Population
- Increased Gut Levels of Lactobacillus and Lactococcus
- Increased Gut Microbial Supplementation
- Increased IPA Levels
- Increased Indigenous Bifidobacterium Levels
- Increased Interest in Probiotic Supplements
- Increased Intestinal Bifidobacteria
- Increased Intestinal Bifidobacteria Levels
- Increased Intestinal Bifidobacteria Population
- Increased Intestinal Bifidobacterium Levels
- Increased Intestinal Lactic Acid Bacteria Count
- Increased Intestinal Lactic Acid Bacteria Population
- Increased Intestinal Lactobacilli Counts
- Increased Intestinal Lactobacillus sakei Levels
- Increased Intestinal Motility
- Increased Intestinal Permeability Under Exercise-induced Stress
- Increased Intestinal Retention Safety
- Increased Intestinal Transit Rate
- Increased Intrinsic Bifidobacteria Levels
- Increased Lactic Acid Bacteria Levels
- Increased Lactobacilli Colonization in the Gut
- Increased Lactobacillus Count
- Increased Lactobacillus plantarum Levels
- Increased Levels of Autochthonous Intestinal Bacteria
- Increased Levels of Bifidobacterium infantis in Feces
- Increased Levels of Lactobacillus Paracasei/Casei
- Increased Mast Cells in Mucosal Tissues
- Increased Microbial Viability in Human Gut
- Increased Persistence of Beneficial Bacterial Species
- Increased Persistence of Probiotics in Fecal Matter
- Increased Plasma Serotonin Levels
- Increased Population of Beneficial Gut Bacteria
- Increased Prebiotic Fermentation Activity
- Increased Preference for SCFP-Containing Diet
- Increased Prevalence of Normally Formed Stools
- Increased Prevotella Concentration
- Increased Probiotic B. lactis Levels
- Increased Probiotic Bacteria Abundance
- Increased Probiotic Bacteria Colonization
- Increased Probiotic Bacterial Survival Through Upper Gastrointestinal Transit
- Increased Probiotic Co-existence
- Increased Probiotic Concentration in Stool
- Increased Probiotic Consumption
- Increased Probiotic Genus Proportion
- Increased Probiotic Levels
- Increased Probiotic Potential
- Increased Probiotic Tolerance
- Increased Proliferation of Administered Bifidobacteria
- Increased Propionic Acid Production
- Increased Proportion of Bifidobacteria in Gut Microbiota
- Increased Proportion of Verrucomicrobia in Gastrointestinal Microbiome
- Increased Protective Fecal Bifidobacteria
- Increased Relative Abundance of Beneficial Microbiota (Lactobacillus)
- Increased Relative Abundance of Bifidobacterium Animalis
- Increased Resistant Starch
- Increased SCFA Concentration
- Increased SCFA Levels
- Increased SCFA Production
- Increased SCFA-Producing Bacteria
- Increased Safety of Probiotic Use
- Increased Serum Motilin Levels
- Increased Short Chain Fatty Acids
- Increased Short Chain Fatty Acids (SCFAs) Levels
- Increased Short-Chain Fatty Acid Production
- Increased Short-Chain Fatty Acid-Producing Bacteria
- Increased Short-Chain Fatty Acid-Producing Gut Flora
- Increased Short-Chain Fatty Acids (SCFAs) Contents
- Increased Short-Chain Fatty Acids Formation
- Increased Specific Probiotic Strains
- Increased Stool Consistency
- Increased Stool Frequency
- Increased Stool IgA Levels
- Increased Stool Looseness
- Increased Stool Volume
- Increased Tolerance to Gastrointestinal Conditions
- Increased Urinary Abundance of Nutrient-Related Metabolites
- Increased Valeric Acid Levels
- Increased Vasoactive Intestinal Peptide Levels
- Increased Viable Bifidobacteria Counts
- Increased Weekly Spontaneous Bowel Movements
- Increased ZO-1 Production in Ileal Tissues
- Induced Circadian Rhythm-Dependent Short-Chain Fatty Acid Production by Gut Microbiota
- Lack of Long-Term Colonization of Bifidobacteria Strains
- Maintained Digestive Function
- Maintained Fecal Short Chain Fatty Acid Levels
- Maintained Gastrointestinal Health
- Maintained Gastrointestinal Microbiome Stability
- Maintained Gut Health
- Maintained Gut Homeostasis
- Maintained Gut Microbiome Composition
- Maintained Gut Microbiota Stability
- Maintained Gut Permeability
- Maintained Intestinal Barrier Integrity
- Maintained Intestinal Epithelial Homeostasis
- Maintained Intestinal Microbial Abundance
- Maintained Intestinal Microbiota Balance
- Maintained Intestinal Microbiota Stability
- Maintained Microbiota Equilibrium
- Maintained Mucosal Barrier Integrity
- Maintained Mucus Barrier Integrity
- Maintained Prevotella-Dominant Gut Microbiota
- Maintenance of Normal Intestinal Function
- Maintenance of Stable Gut Microbiota Profile
- Maintenance of Therapeutic Probiotic Levels
- Managed Gut Microbiota Disturbance
- Mature Gut Microbiota
- Microbial Community Characterization
- Microbial Group Modulation with Bifidobacterial Reduction
- Microbiome Biomarker of Treatment Response
- Microbiome Remodeling
- Mild Gastrointestinal Symptoms
- Moderate Impact on Main GI Bacterial Groups
- Modification of Gastrointestinal Microbiome
- Modified Dominant Intestinal Bacterial Taxa
- Modulated Colonic Microbiota
- Modulated Gastrointestinal Microbiota
- Modulated Gut Microbial Diversity
- Modulated Gut Microbiome Composition
- Modulated Gut Microbiota
- Modulated Intestinal Metabolite Profile
- Modulated Intestinal Microbial Community
- Modulated Intestinal Microbial Taxa
- Modulated Microbiota-Gut-Brain Axis
- Modulation of Microbiota Activity
- Neutral Probiotic Delivery Through Digestion
- No Change in Abnormal Intestinal Permeability
- No Change in Diarrhea
- No Change in Endogenous Bifidobacteria Species
- No Change in Faecal Butyrate Concentration
- No Change in Fecal Metabolome
- No Change in Fecal Short-Chain Fatty Acid Concentration
- No Change in Inflammation Markers
- No Change in Inflammatory or Anti-inflammatory Cytokine Levels
- No Change in Microbial Diversity
- No Change in Symptoms from Apple Oral Challenge
- No Clear Clinical Benefit
- No Clear Effect on Depression
- No Clinically Relevant Changes in Gastrointestinal Quality of Life
- No Conclusive Efficacy
- No Conclusive Long-Term Clinical Benefit
- No Demonstrated Efficacy for Isolated Bifidobacterium Use
- No Improvement in Gastrointestinal Permeability
- No Improvement in Pediatric Irritable Bowel Syndrome Symptoms
- No Increase in Fecal Incontinence
- No Significant Change in Duration of Gastrointestinal Symptoms
- No Significant Change in Gastrointestinal Tolerance
- No Significant Change in Gastrointestinal or General Wellbeing
- No Significant Change in Gut Transit Time
- No Significant Change in IBS Symptom Severity
- No Significant Effect on Toxin-Producing C. difficile Carriage
- No Significant Improvement in Global Gastrointestinal Well-being
- No Worsening of Gastrointestinal Symptoms
- Normalized Gut Metabolites
- Normalized Gut Microbiota
- Normalized Intestinal Microbiota
- Normalized Stool Consistency
- Normalized Stool Type
- Partial Restoration of Intestinal Microbiota
- Potential Probiotic Benefits
- Potential Probiotic Health Effects
- Presence of Lactobacillus johnsonii La1 in Feces
- Presence of Lactobacillus rhamnosus in Feces
- Presence of Lactobacillus salivarius CECT5713 in Feces
- Presence of Lactococcus Lactis in Gut Microbiota
- Presence of Viable L. acidophilus La-5 Strains in Feces
- Preserved Endogenous Bifidobacteria Composition
- Preserved Gut Microbiota Diversity
- Prevented Visceral Hyperalgesia
- Probiotic Adherence Variability Based on Host Factors
- Production of Probiotic Peptides
- Promotion of Healthy Gut Microbial Colonization
- Protected Intestinal Health
- Rapid Galactooligosaccharide Degradation During Gastrointestinal Transit
- Recovered Microbiome-associated Dysbiosis
- Reduced Abdominal Cramping
- Reduced Abdominal Discomfort
- Reduced Abdominal Distension
- Reduced Abdominal Dysfunction
- Reduced Abdominal Pain Frequency
- Reduced Abdominal Pain Intensity
- Reduced Abdominal Pain Severity
- Reduced Abdominal Pain Severity in Diarrhea-Predominant IBS
- Reduced Abdominal Symptoms
- Reduced Abundance of Enterobacteriaceae Species
- Reduced Abundance of Pathobionts
- Reduced Abundance of Streptococcus Bacteroides Enterococcus Veillonella
- Reduced Acetate to Propionate Ratio
- Reduced Antibiotic-Associated Gut Microbiome Disruption
- Reduced Bacteroides Abundance
- Reduced Bacteroides Fragilis Group Numbers
- Reduced Bifidobacterial Population
- Reduced Bifidobacterium Counts
- Reduced Bitter-Related Organic Acids
- Reduced Bloating
- Reduced Bloating Severity
- Reduced Bowel Discomfort Symptoms
- Reduced Bowel Dysfunction
- Reduced Bowel Movement Frequency
- Reduced Bowel Movement Frequency in IBS-D
- Reduced Bowel Movements
- Reduced Butyrate Production
- Reduced Calprotectin Level
- Reduced Campylobacter jejuni Survival
- Reduced Cholecystokinin Level
- Reduced Circulating Endotoxin
- Reduced Clostridia Counts
- Reduced Clostridium Species Numbers
- Reduced Colic or Irritability
- Reduced Coliform Levels in the Jejunum
- Reduced Colon Pain
- Reduced Colonic Contraction Frequency
- Reduced Colonic Permeability
- Reduced Colonic Transit Time
- Reduced Composite Symptom Score
- Reduced Constipation
- Reduced Constipation Prevalence
- Reduced Constipation Severity
- Reduced Constipation Symptoms
- Reduced Constipation Symptoms in IBS
- Reduced Daily Life Disturbance
- Reduced Day School Absenteeism
- Reduced Days with Defecation Urgency
- Reduced Defecation Frequency
- Reduced Diarrhea Episodes
- Reduced Diarrhea Frequency
- Reduced Diarrhea Incidence
- Reduced Diarrhea Severity
- Reduced Diarrhea Symptoms
- Reduced Difficulty in Defecation
- Reduced Digestive Symptoms
- Reduced Discomfort
- Reduced Duration of Gastrointestinal Symptoms
- Reduced E. coli Adherence in Gut
- Reduced Enteritis Index
- Reduced Enterobacteria Levels
- Reduced Enterobacteriaceae Counts
- Reduced Enterocyte Injury from Capsaicin
- Reduced Epithelial Barrier Disruption
- Reduced Epithelial Permeability
- Reduced Escherichia Vulneris Abundance
- Reduced Excitability of Enteric Neurons
- Reduced FGID Severity
- Reduced Faecal Clostridium Population
- Reduced Faecal Levels of Total Lactobacillus Species
- Reduced Fecal Acetate
- Reduced Fecal Bacterial Enzyme Activity
- Reduced Fecal Coliform Count
- Reduced Fecal Enterobacilli
- Reduced Fecal Escherichia coli Levels
- Reduced Fecal Microbiota Diversity
- Reduced Fecal Odor
- Reduced Fecal Score
- Reduced Fecal p-Cresol Levels
- Reduced Flatulence
- Reduced Flatulence Incidence
- Reduced Flavonifractor Abundance
- Reduced Fluctuations in Intestinal Bacteria
- Reduced Foodborne Pathogen Load
- Reduced Frequency of Defecation
- Reduced Frequency of Functional Gastrointestinal Symptoms
- Reduced Functional Gastrointestinal Symptom Frequency
- Reduced Gastrointestinal Adverse Events
- Reduced Gastrointestinal Discomfort Symptoms
- Reduced Gastrointestinal Disease Incidence in Children
- Reduced Gastrointestinal Disease Symptoms
- Reduced Gastrointestinal Disorder Symptoms
- Reduced Gastrointestinal Symptom
- Reduced Gastrointestinal Symptom Rating Scale Score
- Reduced Gastrointestinal Symptom Severity
- Reduced Gastrointestinal Symptoms
- Reduced Gastrointestinal Symptoms Score
- Reduced Gemmiger formicilis Abundance
- Reduced Genera Romboutsia
- Reduced Gut Barrier Defect
- Reduced Gut Disorders
- Reduced Gut Membrane Barrier Damage
- Reduced Gut Proteobacteria
- Reduced Hard Stool
- Reduced Harmful Bacteria in Intestinal Microbiota
- Reduced Harmful Gut Bacteria
- Reduced Harmful Gut Microbiota
- Reduced Harmful Intestinal Bacteria
- Reduced Harmful Intestinal Metabolites
- Reduced Hyperexcitability of Colonic DRG Neurons
- Reduced IBS Dysphoria
- Reduced IBS Symptom Severity (Diarrhea-Predominant)
- Reduced IBS Symptoms
- Reduced Impact of IBS on Daily Life
- Reduced Incidence of Constipation
- Reduced Incidence of Loose or Watery Stools
- Reduced Incidence of Watery Diarrhea
- Reduced Interference Score
- Reduced Interference with Daily Life
- Reduced Intestinal Aging
- Reduced Intestinal Hyperpermeability
- Reduced Intestinal Inflammation
- Reduced Intestinal Oxidative Damage
- Reduced Intestinal Pathogen Prevotella
- Reduced Intestinal Pathogenic Bacteria
- Reduced Intestinal Permeability
- Reduced Intestinal Symptoms from Carbohydrate Sensitivity
- Reduced Intestinal Transit Time
- Reduced Irritability
- Reduced Irritable Bowel Syndrome Symptoms
- Reduced Lactose Intolerance Symptoms
- Reduced Lactose-Related Symptoms
- Reduced Low-grade Intestinal Inflammation
- Reduced Metabolic Functions of Intestinal Microbiota
- Reduced Methane Concentration
- Reduced Methane Production
- Reduced Minor Digestive Symptoms
- Reduced Non-Pain Symptoms
- Reduced Noxious Gases in Fecal Matter
- Reduced Occurrence of Soft Stools
- Reduced Odds of Probiotic Lactobacilli Successful Colonization
- Reduced Overall Symptom Score
- Reduced PAC-SYM Score
- Reduced Pain Intensity in Irritable Bowel Syndrome
- Reduced Painful Defecation
- Reduced Percentage of Bacteroidaceae in Gut Microbiota
- Reduced Postprandial Acidification
- Reduced Postprandial Discomfort
- Reduced Postprandial Fullness
- Reduced Prolonged Diarrhea
- Reduced Proportion of Patients with Loose Stools
- Reduced Putrefactive Short-Chain Fatty Acids
- Reduced Relative Abundance of Coriobacteriaceae
- Reduced Risk of Prolonged Diarrhea
- Reduced Ruminococcus Abundance
- Reduced Secretion Consistency
- Reduced Secretory IgA Content in Faeces
- Reduced Sellimonas Abundance
- Reduced Sensation of Incomplete Evacuation
- Reduced Sense of Incomplete Evacuation
- Reduced Serum Diamine Oxidase Activity
- Reduced Serum LPS Levels
- Reduced Serum Serotonin Levels
- Reduced Short-Chain Fatty Acid Levels in Feces
- Reduced Short-Chain Fatty Acid Levels in the Colon
- Reduced Short-Chain Fatty Acids (SCFA)
- Reduced Small Intestinal Transit Time
- Reduced Standard Care Medication Need
- Reduced Stool Frequency
- Reduced Stool Output in Nonrotavirus Diarrhea
- Reduced Stress-Induced Gastrointestinal Symptoms
- Reduced Stress-Induced Intestinal Hyperpermeability
- Reduced Stress-Induced Intestinal Permeability to Mannitol
- Reduced Stress-Mediated Visceral Hyperalgesia
- Reduced Stress-Related Abdominal Dysfunction
- Reduced Sulphite-Reducing Clostridia
- Reduced Susceptibility to Enteric Infection
- Reduced Symptom Severity Scale Score
- Reduced Symptoms
- Reduced Time Spent for Defecation
- Reduced Time to First Formed Stool
- Reduced Total Symptom Score
- Reduced Transepithelial Resistance
- Reduced Turicibacter Abundance
- Reduced Undesirable Fermentation Microbes
- Reduced Urgency of Bowel Movements
- Reduced Visceral Hypersensitivity
- Reduced Visceral Pain
- Reduced Whole Gut Contraction Frequency
- Reduced Whole Gut Transit Time
- Reduced Zonulin Level
- Reestablished Intestinal Microecology
- Regulated Colonic Bacterial Flora
- Regulated Gastrointestinal Function
- Regulated Gut Microbiota
- Regulated Gut Microbiota Metabolic Function
- Regulated Intestinal Barrier Function
- Regulated Intestinal Microbiota
- Regulated Intestinal Microbiota Balance
- Regulated Intestinal Microorganisms
- Relief from Incomplete Evacuation
- Relieved Abdominal Dysfunction
- Relieved Constipation
- Relieved Gastrointestinal Symptoms
- Relieved Intestinal Impairments
- Relieved Postprandial Discomfort
- Remodeled Intestinal Microbiota
- Requirement for Sustained Dosage in Gastrointestinal Tract
- Resolved Moderate Diarrhea
- Restored Colonic Water Transport
- Restored Gut Microbiota
- Restored Gut Microbiota Homeostasis
- Restored Gut Microbiota Structure
- Restored Healthy Gut Microbial Balance
- Restored Intestinal Barrier Function
- Restored Microbial Balance
- Restored Normal Microbiota
- Restored Relative Abundance of Specific Bacteria
- Restored Short-Chain Fatty Acid Levels
- Reversed Microbiome Metabolic Changes
- Safe Use of Lactobacillus reuteri NCIMB 30242
- Safety Profile of Bifidobacterium Infantis
- Safety of Bifidobacterium infantis Supplementation
- Safety of Probiotic Supplementation
- Stabilized Fecal Secondary Bile Acids
- Stabilized Gut Microbiota
- Stabilized Intestinal Microbiota
- Stable Bowel Function
- Stable Fecal pH
- Successful Gut Colonization
- Suppressed Enterobacteriaceae Levels
- Sustained Bifidobacteria Populations
- Symptom Alleviation
- Tolerance to Lactobacillus rhamnosus PRSF-L477
- Transient Replacement of Native Bifidobacterium longum
- Unchanged Cell Numbers of Fecal Bacteria
- Unchanged Colonic Transit Time
- Unchanged Gastrointestinal Symptoms
- Unchanged Gut Microbiota Diversity
- Unchanged Intestinal Morphology
- Unchanged Stool Consistency or Bowel Frequency
- Unchanged Stool Frequency
- Unchanged Symptom Severity
- Viable Probiotic Strain Recovery
- Well Tolerated Probiotic
- Worsened Fecal Scores